收藏切换
The effect of vonoprazan on gastroesophageal reflux disease and its influence on gastric mucosal barrier function
收藏切换
Guanghui LIU, Junfeng SUN
World Clinical Drug | 2025, 46(9) : 939 - 944
Less
收藏切换
World Clinical Drug | 2025, 46(9): 939-944
• Article •
The effect of vonoprazan on gastroesophageal reflux disease and its influence on gastric mucosal barrier function
Full
Guanghui LIU, Junfeng SUN
Affiliations
  • Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
Published: 2025-09-10 doi: 10.13683/j.wph.2025.09.011
Outline
收藏切换
Objective

To explore the efficacy of vonoprazan in patients with gastroesophageal reflux disease(GERD) and its influence on gastric mucosal barrier function.

Methods

A total of 120 GERD patients admitted to our hospital from January 2023 to December 2024 were selected and randomly divided into the observation group and the control group, with 60 cases in each group. The control group was treated with rabeprazole, while the observation group was treated with vonoprazan, both for 4 weeks. The clinical efficacy, Los Angeles classification score, GERD-Q, 24-hour pH resistance monitoring results, pepsinogen(PG) Ⅰ/Ⅱ, gastrin(GAS), motilin(MTL), tumor necrosis factor(TNF)-α, interleukin(IL)-6, and high-sensitivity C-reactive protein(hs-CRP), reflux conditions and adverse reactions were compared between the two groups.

Results

The total effective rate of the observation group was higher than that of the control group(91.67% vs. 76.67%, P<0.05). The Los Angeles classification and GRED-Q score of the observation group were both lower than those of the control group(P<0.05). The number of times the reflux time was ≥5 min, the longest reflux time, and the pH<4 time in the observation group were all less(shorter) than those in the control group(P<0.05) . The levels of PGⅠ/Ⅱ, GAS and MTL in the observation group were all higher than those in the control group(P<0.05), and TNF-α, IL-6 and hs-CRP were all lower(P<0.05).

Conclusion

Vonoprazan has a significant therapeutic effect on GERD and helps repair the gastric mucosal barrier function. Its mechanism might be related to potent acid suppression, anti-inflammation, etc.

vonoprazan  /  gastroesophageal reflux disease  /  gastric mucosal barrier function  /  inflammatory factor  /  proton pump inhibitor
刘光辉, 孙俊锋. 伏诺拉生对胃食管返流病效果及对胃黏膜屏障功能影响. 世界临床药物, 2025 , 46 (9) : 939 -944 . DOI: 10.13683/j.wph.2025.09.011
Guanghui LIU, Junfeng SUN. The effect of vonoprazan on gastroesophageal reflux disease and its influence on gastric mucosal barrier function[J]. World Clinical Drug, 2025 , 46 (9) : 939 -944 . DOI: 10.13683/j.wph.2025.09.011
Year 2025 volume 46 Issue 9
49
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.09.011
  • Receive Date:2025-05-17
  • Online Date:2026-11-09
  • Published:2025-09-10
Article Data
Affiliations
History
  • Received:2025-05-17
Affiliations
    Department of Gastrointestinal Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.09.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT